Exact Mass: 385.0501
Exact Mass Matches: 385.0501
Found 106 metabolites which its exact mass value is equals to given mass value 385.0501,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cefaclor hydrate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate
(-)-Epigallocatechin sulfate
Epigallocatechin sulfate is the sulfated form of epigallocatechin, wherein the sulfate group is attached to the O-3 position. Sulfation is a phase II biotransformation reaction that involves a sulfotransferase enzyme catalyzing the transfer of a sulfo group from a donor cosubstrate, usually 3-phosphoadenosine-5-phosphosulfate (PAPS), to a substrate molecules hydroxyl group (in this case epigallogatechin). Sulfation is involved in a variety of biological processes, including detoxification, hormone regulation, molecular recognition, cell signaling, and viral entry into cells. Epigallocatechin (EGC) is a flavan-3-ol, which are derivatives of flavans that possess a 2-phenyl-3,4-dihydro-2H-chromen-3-ol skeleton. EGC is one of the antioxidant chemicals found in many fruits and teas. This compound possesses an epimer, found notably in green tea, called "gallocatechin" (GC) (PMID: 30917581), with the gallate residue being in an isomeric trans position. Other sources of gallocatechin are bananas, persimmon, and pomegranate. This compound had been shown to have moderate affinity to the human cannabinoid receptor, which may contribute to the health benefits found by consuming green tea.
Hydroxylansoprazole
Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Lansoprazole sulfone
Lansoprazole sulfone is only found in individuals that have used or taken Lansoprazole. Lansoprazole sulfone is a metabolite of Lansoprazole. Lansoprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Alizarin complexone
3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate
(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane
anisodamine
Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].
Azasetron HCl
Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
OXODIPEROXY(PYRIDINE)(1,3-DIMETHYL-3,4,5,6-TETRAHYDRO-2(1H)-PYRIMIDINONE)MOLYBDENUM (IV)
Methyl (2S)-(2-chlorophenyl){[(4-nitrophenyl)sulfonyl]oxy}acetate
6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate
ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate
METHYL 2-(2,4-DICHLORO-5-FLUOROBENZOYL)-3-((4-FLUOROPHENYL)AMINO)ACRYLATE
[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate
tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate
AMMONIUM PENTABORATE TETRAHYDRATE
B5H12NO19-------------- (385.0469)
YS-49
YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3]. YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].
N-{3-Chloro-4-[(2-chlorobenzoyl)amino]phenyl}-2-pyridinecarboxami de
2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid
Arsonic acid,[4-[[4-(dimethylamino)phenyl]azo]phenyl]-, monohydrochloride (9CI)
(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
Azasetron
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate
4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide
tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate
Mavacoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate
2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide
2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide
[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate
(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate
(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide
N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide
(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester
(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione
2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide
Versicolorone(1-)
An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.
(2S)-versicolorone(1-)
An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.
3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide
(S)-5-oxoaverantin(1-)
A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide
N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide
4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea
1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide
3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide
[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate
N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide
[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate
[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
GLUT4-IN-2
GLUT4-IN-2 is a potent and selective GLUT4 inhibitor with IC50s of 11.4 μM and 6.8 μM for GLUT1 and GLUT4, respectively. GLUT4-IN-2 induces cell apoptosis and cell cycle arrest at G0/G1phase. GLUT4-IN-2 shows potent antitumor activity[1].
aristolochicacid iva methyl ester
{"Ingredient_id": "HBIN016810","Ingredient_name": "aristolochicacid iva methyl ester","Alias": "NA","Ingredient_formula": "C19H15NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
